Microfluidic MarketMicrofluidic Market to Surpass US$ 13.8 Billion Threshold by 2025

MICROFLUIDIC MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017–2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Microfluidic Market Overview
Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and
allows to perform significant biological or chemical processing such as sampling, pre-processing
and measurement involved in an assay within a single chip. Microfluidics aids in handling and
examining very small fluid volumes, around micro- (10-6) to atto- (10-18) liter volumes of fluid,
which provides several analytical and economic advantages over the conventional assays.
Microfluidic devices typically requires 10x times less sample volume, thereby allowing less
sample and reagent consumption. Microfluidic devices transfers such small amount of fluid
volume through microfluidic channels, which provides higher surface area to volume ratio,
which further enhance the heat transfer. Increasing advancements in microfluidics such as labon-a-chip device for DNA amplification, purification, separation and sequencing, and single cell
gene-expression profiling is expected to aid in growth of the market. Microfluidic provides
enhanced analytical sensitivity, enhanced temperature control, faster reaction time, cost
efficiency and allows integration of lab routines in a single device.
Request to download and view Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/1086
The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to witness a
robust CAGR of 19.4% over the forecast period (2017–2025).
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Rising demand for point-of-care testing to augment microfluidic market growth
Point-of-care testing (POC Testing) is medical diagnostic testing performed primarily outside
medical care facilities and in close proximity that is at the time and place of patient care. Point-ofcare testing is relatively expensive than regular lab testing; however, it offers appropriate and
immediate results for further clinical management. Microfluidic technology primarily offers three
advantages to POC diagnostic: smaller sample volume, lower test costs, and faster detection time.
Point-of-care testing enables miniaturization and integration of complex functions facilitating their
usage in limited resources.
Continuous innovation strategy adopted by manufacturers is expected to aid in accelerating
growth of the microfluidic market
Adoption of microfluidics as a key technology in medical science and biosensing is increasing
significantly in the recent past. Manufacturers are focusing on continuous innovation in
microfluidic technology such as laboratory-on-a-chip, point-of-care testing, microfluidic enabled
drug delivery systems, and microfluidic gradient generators to enhance their product portfolios.
Introduction of thermoplastic as a new material for microfluidic device fabrication instead of
conventional PDMS polymer, adoption of novel microfluidic flow rate detection method, and
advancement in nanoparticle separation using microfluidic devices is further expected to boost
the microfluidic market in the near future. Microfluidic techniques are being extensively used to
separate micro sized particles such as blood cells, parasites, spores, tumor cells, and bacteria due
to its advantages such as low sample volume, low cost, and miniature sample handing with
precise control. However, to separate submicron particle, nanofluidics is emerging as a suitable
technology for separation.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/1086
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Major factors influencing growth of the microfluidic market is rising demand for point-of-care
(POC) testing and advancements in microfluidic technology to reduce cost of sample analysis
and enabling higher efficiency. Moreover, increasing demand for home healthcare to address
growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance,
in 2017 researchers at the Ewha Womens University developed an endocrine system on chip,
based on microfluidic perfused 3D cell-culture chip which detect the drugs for the treatment of
diabetes by measuring insulin release over time. According to the statistics published by
International Diabetes Federation (IDF), the global prevalence of diabetes is around 424.9
million in 2017, which is expected to increase to 628.6 million in 2045. In addition, increasing
innovation in microfluidics technology is further expected to bolster growth of the market.
Researchers at the Brigham Young University, in April 2017, developed first 3D-print viable
microfluidic device which has size less than 100 micrometers and employed to use in molecular
biology, proteomics and cell biology diagnostic technologies.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/1086
Some of the major players operating in the microfluidic market are Abbott Laboratories,
Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F.
Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc.,
Siemens Healthcare GmbH, and Micronit Microfluidic BV
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

The Global Microfluidic Market, by Material Type (Silicon-Based Microfluidic, Glass-Based Microfluidic, Polymer-Based Microfluidic, and Others), by Application (In Vitro Diagnostic Devices, Drug Delivery Devices and Monitoring Devices), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.8 billion in 2016 and is projected to exhibit a CAGR of 19.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increasing adoption of microfluidic technology to produce miniaturized microfluidic chips used in molecular diagnosis and analysis, is expected to boost growth of the microfluidic market. For instance, in March 2016, 908 Devices Inc. launched, ZipChip, a microfluidic device that provides high quality separation possibilities to mass spectroscopy enabling fast analysis for a broader range of biomolecules.